Advent Therapeutics lands $3M NIH grant to advance therapy to benefit premature infants

Advent Therapeutics is working on a way to prevent a serious lung disease known as bronchopulmonary dysplasia.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 27, 2023 Category: Pharmaceuticals Authors: John George Source Type: news